Durect Corp

NASDAQ:DRRX   4:00:00 PM EDT
1.91
-0.02 (-1.04%)
7:16:15 PM EDT: $1.94 +0.03 (+1.57%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)NA
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.3 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$1.92
50-Day MA$1.46
200-Day MA$0.92
See more pivots

Durect Corp Stock, NASDAQ:DRRX

10240 Bubb Road, Cupertino, California 95014-4166
United States of America
Phone: +1.408.777.1417
Number of Employees: 58

Description

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.